Serum levels of IL-2, IL-10, IL-13, INF-γ, and TNF-α in children with asthma and atopic dermatitis (AD);Surowicze steżenie IL-2, IL-10, IL-13, INF-γ i TNF-α u dzieci chorych na astme i atopowe zapalenie skóry (AZS)

Alergia Astma Immunologia

Volumn 13, Issue 3, 2008, Pages 172-181

  Machura, Edyta ^a,c   Karczewska, Krystyna ^b   Mazur, Bogdan ^b   Jachimowicz, Magdalena ^a  

^a Uniwersytetu Medycznego W Katowicach   (Poland)

^b SUM w Katowicach ^*  (Poland)

^c Katedra i Klinika Pediatrii w Zabrzu   (Poland)

Author keywords

AD; Asthma; Children; Cytokines

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; SCORING SYSTEM; SKIN DEFECT; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION;

EID: 60749135803     PISSN: 14273101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22: 789-815.
2. Humbert M, Corrigan CJ, Kimmitt P i wsp. Relationship between 1L-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156: 704-8.
3. Hamid Q, Boguniewicz M. Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94: 870-76.
4. Boguniewicz M, Leung DY. Atopic dermatitis. J Allergy Clin Immunol 2006; 117: 475-80.
5. Matsumoto K, Inoue H, Fukuyama S i wsp. Decrease of interleukin-10- producing T cells in the peripheral blood of severe unstable atopic asthmatics. Int Arch Allergy Immunol 2004; 134: 295-302.
6. Jeong CW, Ahn KS, Rho NK i wsp. Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs.extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 2003;33:1717-24.
7. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh)1980; 92: 44-7.
8. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23-31.
9. Światowa strategia rozpoznawania, leczenia i prewencji astmy. Raport NHLBI/WHO. Med Prakt; wydanie specjalne 2002; 6: 1-181.
10. Wills-Karp M. Interleukin-13 in asthmapathogenesis. Immunol Rev 2004; 202: 175-90.
11. Berry MA, Parker D, Neale N i wsp. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2004; 114: 1106-1109.
12. Truyen E, Coteur L, Dilissen E i wsp. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006; 6: 202-208.
13. Park SW, Jangm HK, An MH i wsp. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. Chest 2005; 128: 1921-1927.
14. Feleszko W, Zawadzka-Krajewska A, Matysiak K i wsp. Parental tobacco smoking is associated with augmented IL-13 secretion in children with allergic asthma. J Allergy Clin Immunol 2006; 117: 97-102.
15. Huang SK, Xiao HQ, Kleine-Tebbe J i wsp.. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995; 155: 2688-94.
16. Antunez C, Torres MJ, Corzo JL i wsp. Different lymphocyte markers and cytokine expression in peripheral blood mononuclear cells in children with acute atopic dermatitis. Allergol Immunopathol (Madr) 2004; 32: 252-258.
17. Karaman O, Arli O, Uzuner N, i wsp. The effectiveness of asthma therapy alternatives and evaluating the effectivity of asthma therapy by interleukin-13 and interferon gamma levels in children. Allergy Asthma Proc. 2007; 28: 204-9.
18. Kondo N, Kobayashi Y, Shinoda S i wsp. Reduced interferon gamma production by antigen-stimulated cord blood mononuclear cells is a risk factor of allergic disorders-6-year follow-up study. Clin Exp Allergy 1998; 28: 1340-1344.
19. Machura E, Mazur B, Golemiec E i wsp. S. aureus skin colonization in Atopic Dermatitis children is associated with decreased IFN-γ production by peripheral blood CD4+ and CD8+ T cells Pediatr Allergy Immunol 2008; 19: 37-45.
20. Källström E, Roscher I, Andreasson A i wsp. M. Decreased frequency of intracellular INF-γ producing T cells in whole blood preparations from patients with atopic dermatitis. Exp Dermatol 2002; 11: 556-563.
21. Antunez C, Torres MJ, Mayorga C i wsp. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma. Pediatr Allergy Immunol 2006; 17: 166-174.
22. de Blic J, Tillie-Leblond I, Tonnel AB i wsp. Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol 2004; 113: 94-100.
23. Jenmalm MC, van Snick J, Cormont F i wsp. Allergen induced Th1 and Th2 cytokine secretion in relation specific allergen sensitization and atopic symptoms in children. Clin Exp Allergy 2001; 31: 1528-1235.
24. Bottcher MF, Bjurstrom J, Mai XM i wsp. Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children. Pediatr Allergy Immunol 2003; 14: 345-350.
25. Litonjua AA, Sparrow D, Guevarra L i wsp. Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study. Ann Allergy Asthma Immunol 2003; 90: 422-428.
26. Brown V, Warke TJ, Shields MD i wsp. T cell cytokine profiles in childhood asthma. Thorax 2003; 58: 311-316.
27. Cho SH, Stanciu LA, Holgate ST i wsp. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med 2005; 171: 224-230.
28. Magnan AO, Mely LG, Camilla CA, i wsp. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med 2000; 161: 1790-1796.
29. O'Byrne PM. Cytokines or their antagonists for the treatment of asthma. Chest 2006; 130: 244-50.
30. Hughes JM, Rimmer SJ, Salome CM i wsp. Eosinophilia, interleukin-5, and tumour necrosis factor-alpha in asthmatic children. Allergy 2001; 56: 412-418.
31. Yoshizawa Y, Nomaguchi H, Izaki S i wsp. Serum cytokine levels in atopic dermatitis. Clin Exp Dermatol 2002; 27: 225-229.
32. Obase Y, Shimoda T, Kawano T i wsp. Bronchial hyperresponsiveness and airway inflammation in adolescents with asymptomatic childhood asthma. Allergy 2003; 58: 213-20.
33. Tsuji-Takayama K, Suzuki M, Yamamoto M i wsp.The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STATS-responsive intronic enhancer in the IL-10 locus. J Immunol. 2008; 181: 3897-905.
34. Barnes P. IL-10:a key regulator role of allergic disease. Clin Exp Allergy 2001; 31: 667-669.
35. Dunstan JA, Hale J, Breckler L i wsp. Atopic dermatitis in young children is associated with impaired interleukin-10and interferon-gamma responses to allergens, vaccines and colonizing skin and gut bacteria. Clin Exp Allergy 2005; 35: 1309-1317.
36. Noma T, Sugawara Y, Ogawa N, i wsp. Dermatophagoides-induced interleukin-10 production by peripheral blood lymphocytes from patients with asthma in remission. Pediatr Allergy Immunol 2004; 15: 459-468.
37. Antúnez C, Torres MJ, Mayorga C i wsp. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte- associated antigen T cells from patients with acute or chronic atopic dermatitis. Clin Exp Allergy 2004; 34: 559-566.
38. Aleksza M, Irinyi B, Lukács A i wsp. Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis. B J Dermatol 2002; 147: 1135-1141.
39. Howell MD, Novak N, Bieber T i wsp. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005; 125: 738-45.
40. Robinson DS, Tsicopoulos A, Meng Q i wsp. Durham S, Kay AB, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996; 14: 113-117.
41. Ceyhan BB, Enc FY, Sahin S. IL-2 and IL-10 levels in induced sputum and serum samples of asthmatics. J Investig Allergol Clin Immunol 2004; 14: 80-85.
42. Kabbur PM, Carson WF 4th, Guernsey L i wsp.. Interleukin-10 does not mediate inhalational tolerance in a chronic model of ovalbumin-induced allergic airway disease. Cell Immunol 2006; 239: 67-74.
43. Heaton T, Rowe J, Turner S, i wsp. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 2005; 365: 142-9.
44. Stelmach I, Jerzyńska J, Kuna P. Arandomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy 2002; 32: 264-9.
45. Karagiannidis C, Akdis M, Holopainen P i wsp. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-1433.
46. Jeannin P, Lecoanet S, Delneste Y i wsp. IgE versus IgG4 production can be differentially regulated by 1L-10. J Immunol 1998; 160: 3555-3561.